Maurice Jansen

Maurice Jansen is a Researcher at Erasmus MC, Medical Oncology, affiliated with Erasmus University Rotterdam. His work focuses on cancer research, molecular biology, and precision medicine, particularly in ovarian and breast cancers. He contributes to translational research through initiatives like the Archipelago of Ovarian Cancer Research Biobank, emphasizing biobanking infrastructure and genomic profiling.

Key research interests include Circulating Tumor DNA analysis, next-generation sequencing, and drug resistance mechanisms in cancer therapies. Collaborative efforts with institutions globally enhance his work on molecular diagnostics and clinical pathology standards.

Recent studies highlight advancements in multiplex assays for genetic mutations (PIK3CA) and IT infrastructure for biobanking, aiming to improve healthcare data management and clinical trial support. His contributions bridge laboratory findings with clinical applications, advancing personalized oncology.

He has supervised 2 research projects but no award mentions are available. His lab affiliations include the Archipelago Biobank consortium and the COIN Consortium for molecular tumor profiling.